KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,273,000 | +100.2% | 139,462 | +6.5% | 0.02% | +87.5% |
Q2 2020 | $2,134,000 | -8.6% | 130,898 | -44.2% | 0.01% | -38.5% |
Q1 2020 | $2,334,000 | +1.8% | 234,560 | +40.6% | 0.01% | +8.3% |
Q4 2019 | $2,293,000 | +696.2% | 166,774 | +778.0% | 0.01% | +500.0% |
Q3 2019 | $288,000 | -23.0% | 18,994 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $374,000 | +16.9% | 18,994 | -1.5% | 0.00% | 0.0% |
Q1 2019 | $320,000 | – | 19,288 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |